Breaking News Instant updates and real-time market news.

LDOS

Leidos

$82.50

-0.66 (-0.79%)

16:31
10/14/19
10/14
16:31
10/14/19
16:31

Leidos awarded $926M TSA screening equipment contract

Leidos was awarded a follow-on prime contract to continue providing maintenance, sustainment and logistics support services for the Transportation Security Administration's checkpoint screening equipment. The single award, fixed unit price contract has a four-month base period of performance, four one-year options, followed by an eight-month option, and a total approximate value of more than $926M if all options are exercised. Work will be performed nationwide. Under the contract, the company will provide services that include: preventative, corrective, and depot maintenance; integrated logistics support, information technology infrastructure development and maintenance; and management of TSA's Service Response Center.

  • 29

    Oct

  • 12

    Nov

LDOS Leidos
$82.50

-0.66 (-0.79%)

07/09/19
SBSH
07/09/19
DOWNGRADE
Target $83
SBSH
Neutral
Leidos downgraded to Neutral from Buy at Citi
Citi analyst Jonathan Raviv downgraded both CACI International (CACI) and Leidos (LDOS) to Neutral from Buy citing valuation. While the company's fundamentals "look good," shares of Leidos are up 54% year-to-date, Raviv tells investors in a research note. He raised his price target for Leidos shares to $83 from $75 despite the downgrade. The analyst maintains a Buy rating on SAIC (SAIC) with a $100 price target, saying the company's enjoys "more valuation cushion" yielding greater than 10%.
07/31/19
RHCO
07/31/19
NO CHANGE
Target $95
RHCO
Buy
Leidos price target raised to $95 from $79 at SunTrust
SunTrust analyst Tobey Sommer raised his price target on Leidos to $95 and kept his Buy rating after its Q2 earnings beat and raised FY19 guidance. The analyst is more optimistic that the company can generate a "sustainable mid- to high-single digit" revenue growth over the medium term, supported by "elevated" win rates and contracts such as the $2.9B NASA IT Services deal grated earlier this year and the Air Combat Command's Intelligence Surveillance, Reconnaissance Support Services Program.
09/20/19
LEHM
09/20/19
INITIATION
Target $97
LEHM
Equal Weight
Leidos initiated with an Equal Weight at Barclays
Barclays analyst David Strauss started Leidos Holdings with an Equal Weight rating and $97 price target. The analyst initiated coverage of U.S. government services and is selective on the stocks given recent outperformance, noting that valuations are now ~10% above large cap defense. The analyst believes Leidos' non-Department of Defense exposure provides support in a future defense downturn, but he sees less margin upside versus peers.
09/24/19
JPMS
09/24/19
INITIATION
Target $95
JPMS
Neutral
Leidos initiated with a Neutral at JPMorgan
JPMorgan analyst Seth Seifman started Leidos Holdings with a Neutral rating and $95 price target. With a valuation above the historical average, the analyst does not expect much multiple expansion for Leidos.

TODAY'S FREE FLY STORIES

TVTY

Tivity Health

$18.42

0.005 (0.03%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Earnings
Tivity Health reports Q3 adjusted EPS 46c, consensus 56c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 10

    Dec

I

Intelsat

$20.80

-2.435 (-10.48%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Downgrade
Intelsat rating change  »

Intelsat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

TH

Target Hospitality

$5.03

-0.23 (-4.37%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Earnings
Target Hospitality cuts FY19 revenue view to $318M-$328M from $340M-$350M »

Consensus $340.38M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 18

    Nov

MTSI

Macom

$24.38

0.93 (3.97%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Earnings
Macom sees Q1 adj. EPS 1c-5c, consensus 1c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

RUN

Sunrun

$14.44

0.03 (0.21%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Hot Stocks
Sunrun board authorizes $50M stock repurchase program »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 04

    Dec

NBRV

Nabriva Therapeutics

$1.96

-0.03 (-1.51%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Earnings
Nabriva Therapeutics reports Q3 EPS (90c), consensus (28c) »

Reports Q3 revenue $461K,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CRNX

Crinetics

$19.16

-0.34 (-1.74%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Earnings
Crinetics reports Q3 EPS (60c), consensus (57c) »

Reports Q3 revenue $505K,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRAY

ViewRay

$2.48

-0.14 (-5.34%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Earnings
ViewRay reaffirms FY19 revenue view $80M-$95M, consensus $89.28M »

Sees FY19 total cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

RUN

Sunrun

$14.48

0.065 (0.45%)

16:11
11/12/19
11/12
16:11
11/12/19
16:11
Hot Stocks
Breaking Hot Stocks news story on Sunrun »

Sunrun sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 04

    Dec

TH

Target Hospitality

$4.99

-0.27 (-5.13%)

16:10
11/12/19
11/12
16:10
11/12/19
16:10
Earnings
Target Hospitality reports Q3 adjusted EPS 11c, consensus 15c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 18

    Nov

RUN

Sunrun

$14.44

0.03 (0.21%)

16:10
11/12/19
11/12
16:10
11/12/19
16:10
Earnings
Sunrun reports Q3 EPS 23c, consensus 15c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 04

    Dec

VRAY

ViewRay

$2.48

-0.145 (-5.53%)

16:10
11/12/19
11/12
16:10
11/12/19
16:10
Earnings
ViewRay reports Q3 EPS (21c), consensus (27c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

MTSI

Macom

$24.22

0.77 (3.28%)

16:10
11/12/19
11/12
16:10
11/12/19
16:10
Earnings
Macom reports Q4 adj. EPS 1c, consensus (2c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

MYO

Myomo

$0.65

-0.051 (-7.25%)

16:09
11/12/19
11/12
16:09
11/12/19
16:09
Earnings
Myomo reports Q3 EPS (16c), consensus (16c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BDSI

BioDelivery Sciences

$5.84

(0.00%)

16:09
11/12/19
11/12
16:09
11/12/19
16:09
Earnings
BioDelivery Sciences raises FY19 revenue view to $105M-$110M from $101M - $105M »

Consensus for FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 17

    Dec

MYO

Myomo

$0.65

-0.051 (-7.25%)

16:09
11/12/19
11/12
16:09
11/12/19
16:09
Earnings
Myomo reports Q3 EPS (16c), consensus (16c) »

Myomo reports Q3 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

AGTC

Applied Genetic

$3.15

-0.005 (-0.16%)

16:09
11/12/19
11/12
16:09
11/12/19
16:09
Earnings
Applied Genetic reports Q3 EPS (64c), consensus (60c) »

As of September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

  • 04

    Dec

CLPR

Clipper Realty

$9.76

-0.18 (-1.81%)

16:09
11/12/19
11/12
16:09
11/12/19
16:09
Earnings
Clipper Realty reports Q3 adjusted FFO 12, consensus 12c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

MRKR

Marker Therapeutics

$3.91

-0.08 (-2.01%)

16:08
11/12/19
11/12
16:08
11/12/19
16:08
Earnings
Marker Therapeutics reports Q3 EPS (12c), consensus (13c) »

At September 30 Marker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CRTX

Cortexyme

$22.80

-0.7 (-2.98%)

16:08
11/12/19
11/12
16:08
11/12/19
16:08
Earnings
Cortexyme reports Q3 EPS (37c), consensus (37c) »

"The GAIN Trial has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LONE

Lonestar Resources

$2.67

-0.21 (-7.29%)

16:07
11/12/19
11/12
16:07
11/12/19
16:07
Downgrade
Lonestar Resources rating change  »

Lonestar Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TLRY

Tilray

$21.26

-0.71 (-3.23%)

16:07
11/12/19
11/12
16:07
11/12/19
16:07
Earnings
Tilray reports Q3 adjusted EPS (50c), consensus (29c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

16:07
11/12/19
11/12
16:07
11/12/19
16:07
Conference/Events
Stephens business services analyst to hold a group luncheon »

Group Luncheon Meeting to…

BDSI

BioDelivery Sciences

$5.85

0.01 (0.17%)

16:07
11/12/19
11/12
16:07
11/12/19
16:07
Earnings
BioDelivery Sciences reports Q3 EPS 0c, consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 17

    Dec

TWOU

2U

$22.85

1.04 (4.77%)

16:07
11/12/19
11/12
16:07
11/12/19
16:07
Earnings
2U sees FY19 adjusted EPS ($3.89)-($3.79), may not compare to consensus ($1.19) »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.